Genomic Health, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced total revenue was USD 108.769 million compared to USD 92.625 million a year ago. Operating income was USD 11.539 million compared to of USD 4.388 million a year ago. Net income was USD 12.999 million compared to net loss of USD 3.775 million a year ago. Basic earnings per share was USD 0.35 compared to basic loss per share of USD 0.11 a year ago. Diluted earnings per share was USD 0.34 compared to diluted loss per share of USD 0.11 a year ago.